1 / 47

Why are we here together ? (i.e., diabetes and CVD?)

Synergies in Prevention for Diabetes and Cardiovascular Disease: Why are we here together? Edward Gregg, PhD Division of Diabetes Translation Centers for Disease Control and Prevention Atlanta, GA. The findings and conclusions of this presentation are those of the presenter and do not necessarily

Download Presentation

Why are we here together ? (i.e., diabetes and CVD?)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Synergies in Prevention for Diabetes and Cardiovascular Disease:Why are we here together?Edward Gregg, PhDDivision of Diabetes TranslationCenters for Disease Control and PreventionAtlanta, GA The findings and conclusions of this presentation are those of the presenter and do not necessarily represent views of the Centers for Disease Control and Prevention.

  2. Why are we here together? (i.e., diabetes and CVD?) • What are the most effective, synergistic public health approaches for diabetes and cardiovascular disease prevention and control?

  3. Crude and Age-Adjusted Incidence of Diagnosed Diabetes per 1,000 Population Aged 18–79 Years, United States, 1980–2010

  4. Projected Prevalence of Diabetes (Diagnosed or Undiagnosed) Under Scenarios of No further Increase Continued Increased Incidence Rate Boyle et al., Pop Health Metrics, 2010

  5. County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2004 Percent www.cdc.gov/diabetes

  6. County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years: United States 2005 County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2005 Percent www.cdc.gov/diabetes

  7. County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years: United States 2006 County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2006 Percent www.cdc.gov/diabetes

  8. County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years: United States 2007 County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2007 Percent www.cdc.gov/diabetes

  9. County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years: United States 2008 County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2008 Percent www.cdc.gov/diabetes

  10. County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years: United States 2009 County-level County-Level Estimates of Diagnosed Diabetes Among U.S. Adults Aged ≥20 Years: 2009 Percent www.cdc.gov/diabetes

  11. Heart Disease and Strokes:Leading Killers in the United States • Cause 1 of every 3 deaths • More than 1 of 3 (83 million) U.S. adults currently lives with one or more types of cardiovascular disease. • Over 2 million heart attacks and strokes each year • $444 B in health care costs and lost productivity • Greatest contributor to racial disparities in life expectancy Roger VL, et al. Circulation 2012;125:e2-e220 Heidenriech PA, et al. Circulation 2011;123:933–4 12

  12. The Burden of Diabetes, Heart Disease, and Stroke in Maine

  13. The Burden of Diabetes in Maine Trends in Incidence of Diagnosed Diabetes among Adults, Maine, 1996 - 2010 Diabetes Surveillance Report, Maine, 2012 National Diabetes Surveillance System, www.cdc.gov/diabetes

  14. Burden of Heart Disease, Stroke, and Related Risk Factors in Maine

  15. Heart Disease And Stroke Diabetes: Undiagnosed Diabetes Untreated and / or Un-detected Risk Factors and Sub-clinical Disease Dysglycemia “Pre-diabetes”

  16. Central Obesity Physical Inactivity Sugared Beverages Hypertension Unhealthy dietary fat Inadequate nuts, grains, fruits, vegetables Smoking Very low birth weight Poor Sleep Depression Primary Modifiable Risk FactorsDiabetes Cardiovascular Disease • Smoking • High LDL cholesterol • Hypertension • Physical Inactivity • High Blood Glucose • Central Obesity • Unhealthy dietary fat • Excess salt intake • Chronic kidney disease • Psychosocial Stress • Very low birth weight

  17. What can we learn from the epidemiologic trends in chronic diseases and related risk factors? Deaths/100,000 from heart disease and stroke, United States, 1900-2005. Sources:1900 – 1978: NCHS Vital Statistics historical tabulated date; 1979-2005: CDC Wonder.

  18. Trends in Annual Incidence of Diabetes Related Complications Over 2 Decades Among U.S. Adults with Diabetes Cases per 10,000/year Year National Diabetes Surveillance System; www.cdc.gov/diabetes;

  19. Clinical and Public Health Progress Each Contributed About Half to the 50% Reduction in Heart Disease Deaths, US, 1980−2000 Risk factor reductions = ~50% Clinical interventions = ~50% BMI increases Diabetes increases HTN, statins Smoking reduction Physical inactivity Cholesterol reduction Systolic BP reduction Initial treatments for heart attack or acute angina Treatments for heart failure Secondary preventive therapies Revascularization for chronic angina Ford ES, et al. NEJM 2007;356(23):2388-97 HTN, Hypertension BP, Blood pressure BMI, Body mass index 22

  20. Greatest Improvements in targets for: • Lipid Levels: 20.8 % points • Blood pressure: 11.7 % points • Glycemic control: 9.4 % points • Remaining Concerns: • 33 to 48% did not meet targets. • No improvement in tobacco. • Only 14% met targets for all 4.

  21. General Trends in Secondary and Primary Prevention of Cardiometabolic Disease Challenges in Primary Prevention Relative Successes: Secondary Prevention and Control of Risk Factors • CVD Mortality • MI, Stroke • Diabetes Complications • Amputations • Acute • ESRD • CVD Risk Factors • HTN control • Lipids • Smoking • Preventive Care • Diabetes Incidence • Obesity • Cardiometabolic risk in youth 1990 1995 2000 2005 2010 1990 1995 2000 2005 2010 Status Unclear: Hypertension Chronic Kidney Disease Disparities in Vulnerable Groups

  22. Why are we here together? (i.e., diabetes and CVD?) • We’re both important. • We share a large, common constituency. • We share many, common, highly modifiable risk factors. • We both have some important past successes. • Evolving science points us toward some key synergistic approaches. • What are the most effective, synergistic public health approaches for diabetes and cardiovascular disease prevention and control?

  23. Classic Public Health Avenues for Prevention of Cardiovascular Disease • Healthy Diet • Physical activity • Med Adherence • Smoking Cessation • BP control • Lipid control • Smoking Cessation • Glycemic Control • Targeted screening

  24. Where gaps remain, stimulate, support, and facilitate team-based prevention and care.

  25. Lancet, 2012

  26. Tricco et al., Lancet, 2012

  27. Develop and support effective models of self-management.

  28. Elements and Impact of Self-Management Education for Diabetes and Hypertension • Small group attention. • Knowledge, skills, and ability. • Active Collaboration • Problem solving • Tailored to individual differences • Ongoing Support • Behavioral Goal Setting • Glycemic Control • Blood pressure control • Healthy Behaviors • Preventive Screening • Clinical Outcomes • Health Status • Quality of Life

  29. Police EMS Corrections MCOs Health Department Philanthropist Places of Worship Community Centers Nursing Homes Home Health Parks Doctors Schools Elected Officials Hospitals Mass Transit Environmental Health Civic Groups CHCs Fire Tribal Health Employers Laboratory Facilities Economic Development Drug Treatment Mental Health Building effective networks and clinical-community partnerships.

  30. The National Diabetes Prevention ProgramA Community–Clinic–Payer–Agency Partnership Model Clinic Community Insurers Proactive Practice Team Reimbursement Employers Screening for High Risk Diagnosis of Prediabetes Informed Population Decision Support Partnership Zone Strong Community Organizations Structured Lifestyle Programs Information Systems Healthy Public Policy Regular Glucose Monitoring Informed, Activated Patients Supportive Environments Total Population Complications Pre-diabetes Diabetes

  31. The National Diabetes Prevention Program: A Public-private partnership to systematically scale the translated model of the DPP.

  32. First Author- Weight (Year of Publication) Change (95% CI) Medical and Allied Health Professionals Aldana-(2005) -5.50 (-13.14, 2.14) Davis-Smith-(2007) -4.60 (-19.10, 9.90) Siedel-(2008) -5.10 (-11.18, 0.98) MCBride-(2008) -4.10 (-10.57, 2.37) Pagoto-(2008) -4.60 (-8.32, -0.88) Boltri-(2008) -0.50 (-5.40, 4.40) Matvienko-(2009) -6.10 (-15.51, 3.31) Amundson-(2009) -6.70 (-9.64, -3.76) McTigue-(2009) -4.80 (-9.90, 0.30) Whittemore-(2009) -4.80 (-13.42, 3.82) Kramer- (2009) -2.20 (-6.32, 1.92) Kramer-(2009) -4.50 (-10.77, 1.77) Vanderwood-(2010) -7.90 (-10.06, -5.74) Kramer-(2010) -6.60 (-15.81, 2.61) Almeida-(2010) -1.60 (-2.38, -0.82) Vadheim-(2010) -8.60 (-15.46, -1.74) Bersoux-(2010) -2.90 (-7.60, 1.80) Jaber-(2011) -5.70 (-11.58, 0.18) Boltri-(2011) -0.85 (-3.79, 2.09) Subtotal -4.27 (-5.85, -2.70) Lay Community Members Ackerman-(2008) -6.00 (-14.62, 2.62) Parikh-(2010) -4.30 (-10.96, 2.36) Mau-(2010) -1.50 (-3.34, 0.34) Faridi-(2010) -1.60 (-4.34, 1.14) Katula-(2011) -7.40 (-11.71, -3.09) Subtotal -3.15 (-5.46, -0.83) Electronic-Media Assisted Tate-(2005) -5.10 (-12.16, 1.96) Estabrooks-(2008) -2.60 (-8.48, 3.28) McTigue-(2009) -4.70 (-10.97, 1.57) Kramer- (2010) -5.60 (-15.20, 4.00) Subtotal -4.20 (-7.62, -0.77) Overall -3.99 (-5.16, -2.83) -15 -10 -5 0 0 5 10 15 Percentage weight change Favors Intervention No intervention effect • 26 studies of 3797 high risk adults: • Diverse settings: • 12 community (recreation, faith) • 11 health care • Mean weight change: 4% • Every 4 sessions attended: 1% percentage point added weight loss • Aggregate cost: ~ 1000 per person Ali et al., Health Affairs, 2012

  33. Progress To-date for National Diabeters Prevention Program • Over 1400 lifestyle coaches trained. • Over 320 organizations awarded CDC recognition (pending) • Five private insurers and 280 self-funded employers covering program • 6 National CDC grantees March 19, 2013

  34. Effects of Weight Loss And/or Sodium Restriction on 4-year Hypertension Incidence Among Overweight Individuals Aged 30-54 With High-normal Blood Pressure (TOHP II Collaborative Research Group, Arch Intern Med, 1997)

  35. Physical environment • Food environment • Social environment • Economy and poverty Frieden, Am J Public Health, 2009

  36. Policy Options to Influence Cardiometabolic Risk • Tobacco-free and clean air legislation. • Physical education in schools. • Physical activity in worksites. • Incentives for healthier food options and famers markets. • Influence access to healthy foods and beverages in public and educational settings. • Sodium Reduction and trans fat elimination. • Food and Menu labeling • Regulation of foods in public areas. • Community design for physical activity.

  37. Promising Targets for Population-Wide Food Policies to Influence Cardiometabolic Risk

  38. Why are we here together? (i.e., diabetes and CVD?) • What are the most effective, synergistic public health approaches for diabetes and cardiovascular disease prevention and control? • Enhance and support team-based care. • Support effective models of self-management. • Develop and support effective, evidence-based clinical-community partnerships. • Creatively change our environment to make prevention easier.

  39. Our Role in Public Health • Population perspective. • Link health systems with communities and policies. • Unified measurement and strong evaluation to drive quality and action. • Synergistic interventions to improve efficiency and outcomes.

  40. Can we develop smarter, more useful quality metrics? • Personalized Risk-based Scores • Patient Reported Measures • Clinical Action Measures • Measures that include resource use

  41. What has worked in secondary prevention? • Health Services: • Acute care and major medical interventions • Diffusion of new science of risk factor management • Emphasis on quality of care • Health system adaptation and CQI • Health Promotion and Health Protection • Improved education/awareness of diabetes control. • Improved CVD risk factor education and awareness. • Reduced Tobacco / tobacco legislation • Less directly atherogenic food supply • Legislation of diabetes care and supplies.

More Related